DWM
ABBV icon

Darwin Wealth Management’s AbbVie ABBV Stock Holding History

Darwin Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Buy
1,924
+195
+11% +$42K 0.13% 99
2026
Q1 		$376K Buy
1,729
+124
+8% +$27.5K 0.12% 105
2025
Q4 		$367K Sell
1,605
-2
-0.1% -$456 0.11% 109
2025
Q3 		$372K Buy
1,607
+117
+8% +$23.8K 0.12% 108
2025
Q2 		$277K Sell
1,490
-290
-16% -$53.9K 0.1% 114
2025
Q1 		$316K Hold
1,780
– – 0.11% 109
2024
Q4 		$316K Sell
1,780
-158
-8% -$29K 0.11% 109
2024
Q3 		$383K Sell
1,938
-53
-3% -$9.89K 0.11% 106
2024
Q2 		$341K Buy
1,991
+110
+6% +$18.2K 0.17% 59
2024
Q1 		$343K Sell
1,881
-682
-27% -$118K 0.1% 107
2023
Q4 		$397K Sell
2,563
-117
-4% -$17.1K 0.11% 102
2023
Q3 		$399K Buy
2,680
+78
+3% +$11.5K 0.11% 101
2023
Q2 		$353K Buy
2,602
+714
+38% +$105K 0.09% 107
2023
Q1 		$304K Sell
1,888
-51
-3% -$7.8K 0.08% 119
2022
Q4 		$298K Sell
1,939
-420
-18% -$64.4K 0.08% 135
2022
Q3 		$341K Sell
2,359
-127
-5% -$18.2K 0.09% 121
2022
Q2 		$349K Buy
+2,486
New +$380K 0.07% 129
2020
Q2 		– Sell
-2,411
Closed -$182K – 160
2020
Q1 		$182K Sell
2,411
-89
-4% -$7.58K 0.06% 137
2019
Q4 		$221K Buy
+2,500
New +$208K 0.06% 143
2019
Q2 		– Sell
-2,829
Closed -$228K – 147
2019
Q1 		$228K Buy
2,829
+607
+27% +$49.7K 0.08% 136
2018
Q4 		$206K Buy
+2,222
New +$195K 0.14% 91

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Darwin Wealth Management's ABBV Position: Q2 2026 in Review

Darwin Wealth Management increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $42K and bringing the position to 1,924 shares worth $484K. The position accounts for 0.13% of the portfolio, ranked #99.

Darwin Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 21 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Darwin Wealth Management held 1,924 shares of AbbVie worth $484K as of Q2 2026.
  • Darwin Wealth Management bought 195 AbbVie shares in Q2 2026, an estimated $42K.
  • AbbVie made up 0.13% of Darwin Wealth Management's portfolio in Q2 2026, its #99 holding.
  • Darwin Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 21 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.